Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Alkem Laboratories launches Semaglutide injection in India, with weekly therapy starting at INR 450/- ".
Press Release Mar 21 2026
Filed with NSE · · 3 pages · English
Release
Alkem Laboratories Ltd. on 6ix
Earlier from Alkem Laboratories
- Press Release Mar 20 2026
- Press Release Feb 13 2026
- Press Release Jan 08 2026
- Press Release Nov 20 2025
- Press Release (Revised) Nov 03 2025
Later from Alkem Laboratories
- Press Release Apr 07 2026
- Press Release May 08 2026
- Press Release Jun 02 2026
- Alkem Laboratories Ltd. Press Release Sep 08 2026
- Alkem Laboratories Ltd. Press Release Sep 16 2026
Follow Alkem Laboratories into a list and get an email when it puts out news.
Follow Alkem Laboratories